Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vomiting 1Ovarian Neoplasms 1Nausea 1Fallopian Tube Neoplasms 1Brenner Tumor 1

Interventions

Paclitaxel 11Carboplatin 7Cisplatin 5Taxes 4paclitaxel poliglumex 2Topotecan 2Etoposide 2elesclomol 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Watchful Waiting 1VTX-2337 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Observation 1Mitoxantrone 1Methods 1Mental Status and Dementia Tests 1Granisetron 1Educational Status 1Early Intervention, Educational 1Dexamethasone 1Cyclophosphamide 1Counseling 1Chemotherapy, Adjuvant 1Calcium Dobesilate 1Aprepitant 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Brenner Tumor × Aprepitant × Clear all
NCT01275664 2018-05-22

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

GOG Foundation

Phase NA Terminated
4 enrolled 5 charts
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Nausea, Ovarian Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡